Admin Posted December 24, 2011 Share Posted December 24, 2011 Back in September 2011 we reported that Chuck Maack, an American supporter of men with prostate cancer, was taking abiraterone/Zytiga 'off label'. 'Off label' means your doctor is giving you a drug for a use that has not yet been approved, and not as part of a trial. 'On label' for abiraterone/Zytiga in the USA is after chemotherapy. Chuck's use is off label because he is using it before chemotherapy, rather than other secondary hormone therapy drugs like ketoconazole or nilutamide. Off label usually means that you meet the full cost of the drug. Chuck's 6 months of treatment will probably cost $30,000. Chuck updated his status on Christmas Eve to say that after almost 4 months of treatment his PSA has dropped significantly, testosterone has dropped, and there were no cancer cells circulating in his blood. Read the details in the latest reply to the original topic here: Abiraterone before chemotherapy or Abiraterone before chemotherapy Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.